6SQB Sequans Communications S.A. ADS

Sequans Communications S.A. Announces Launch of Public Offering of American Depositary Shares

Sequans Communications S.A. (NYSE: SQNS) (the “Company” or “SQNS”), a leading developer and provider of 5G and 4G chips and modules for IoT devices, today announced the launch of an underwritten registered public offering of its American Depositary Shares. Each American Depositary Share represents four ordinary shares of the Company, nominal value €0.02 per share (the “ADSs”). The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of its ADSs sold in the proposed offering. All ADSs to be sold in the proposed offering will be offered by the Company. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The Company intends to use the net proceeds from the offering, if completed, for general corporate purposes, which may include 5G product development. Upon the closing of the offering, Sequans will terminate its At Market Issuance Sales Agreement, dated March 31, 2020.

B. Riley FBR is acting as sole bookrunner for the offering. Roth Capital Partners is acting as co-manager for the offering.

The proposed offering is being made pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-221919) that was declared effective by the Securities and Exchange Commission (“SEC”) on December 22, 2017. The ADSs may be offered only by means of a prospectus. A preliminary prospectus supplement describing the terms of the proposed offering and the accompanying base prospectus will be filed with the SEC and will be available on the SEC’s website located at . Alternatively, copies of the preliminary prospectus supplement and accompanying prospectus relating to the proposed offering, when available, may be obtained from B. Riley FBR, Inc., Attention: Prospectus Department, 1300 17th St. North, Ste. 1300, Arlington, VA 22209, or by email at , or by telephone at (703) 312-9580. The final terms of the proposed offering will be disclosed in a final prospectus supplement to be filed with the SEC.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Sequans Communications

Sequans Communications S.A. (NYSE: SQNS) is a leading developer and provider of 5G and 4G chips and modules for IoT devices. For 5G/4G massive IoT applications, Sequans provides a comprehensive product portfolio based on its flagship Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, featuring industry-leading low power consumption, a large set of integrated functionalities, and global deployment capability. For 5G/4G broadband and critical IoT applications, Sequans offers a product portfolio based on its Cassiopeia 4G Cat 4/Cat 6 and high-end Taurus 5G chip platforms, optimized for low-cost residential, enterprise, and industrial applications. Founded in 2003, Sequans is based in Paris, France with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Sweden, Taiwan, South Korea, and China.

Forward-Looking Statements

This press release contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “will,” and similar expressions are intended to identify forward-looking statements. The forward-looking statements in this press release include statements about the Company’s expectations regarding the completion of its proposed public offering, its expectations with respect to granting the underwriters a 30-day option to purchase additional ADSs and the anticipated use of proceeds from the offering. These statements involve risks, estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in these statements, including, among others, risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering, as well as risks and uncertainties associated with the Company’s business and finances in general. In addition, please refer to the risk factors contained in the Company’s Form 20-F for the fiscal year ended December 31, 2019 and other SEC filings available at . Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. The Company undertakes no obligation to update or revise any forward-looking statements for any reason, except as required by law.

EN
11/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sequans Communications S.A. ADS

Sequans Communications SA: 1 director

A director at Sequans Communications SA sold 13,000 shares at 4.720USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

 PRESS RELEASE

Sequans and AmericanPharma Technologies Team Up to Protect Covid-19 Va...

PARIS & BOISE, Idaho--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS) has joined forces with AmericanPharma Technologies and is providing the cellular IoT connectivity solution for AmericanPharma Tech’s PharmaWatch™ vaccine monitoring system that is currently protecting Covid-19 vaccine shipments and storage around the country. PharmaWatch is connected by Sequans’ Monarch technology, enabling it to upload its vaccine temperature monitoring data to the portal every 5 minutes via a secure and reliable cellular LTE-M network transmission. “PharmaWatch provides one of the most importan...

 PRESS RELEASE

Sequans to Participate in Needham 2021 Virtual Technology and Media Co...

PARIS--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS), leading developer and provider of 5G and 4G solutions for broadband, critical, and massive IoT, announced today Georges Karam, CEO and Deborah Choate, CFO, will participate in the Needham Technology and Media Conference being held virtually May 17-20, 2021. Sequans will conduct one-on-one meetings on Monday, May 17th and Tuesday, May 18th between 8:00 am and 1:30 pm ET. The Company will participate in a fireside chat from 8:00 am to 8:40 am ET on Monday, May 17th. For more information about the Needham conference, or to sched...

 PRESS RELEASE

Sequans Communications Announces First Quarter 2021 Financial Results

PARIS--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS), a leading developer and provider of 5G/4G chips and modules, today announced financial results for the first quarter ended March 31, 2021. First Quarter 2021 Summary Results Table: (in US$ millions, except share and per share data) Q1 2021   Q4 2020   Q1 2020 Revenue $12.3     $15.8     $8.8   Gross profit 6.2     7.1     4.5   Gross margin (%) 50.1 %   45.1 %   51.3 % Operating loss (5.8 )   (5.4 )   (7.8 ) Net loss ...

 PRESS RELEASE

Sequans Announces $50 Million Financing to Strengthen Balance Sheet

PARIS--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS), leading developer and provider of 5G and 4G solutions for broadband, critical, and massive IoT, announced today the signing of a $50 million private financing with Lynrock Lake Master Fund LP, a fund managed by Lynrock Lake LP (“Lynrock Lake”), an investment management firm with approximately $1.2 billion of assets under management. The financing consists of $10 million of American Depository Shares (ADS) and $40 million principal amount of convertible debt. The financing is scheduled to close April 9, 2021. “A stronger balanc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch